2023-11-08T14:45:16-06:00 2022-12-31 410746749 CLIFTONLARSONALLEN LLP 901 N GLEBE ROAD SUITE 200 ARLINGTON VA 22203 990 2022-01-01 521006053 ADVANCED MEDICAL TECHNOLOGY ASSOCIATION ADVA 2027838700 1301 PENNSYLVANIA AVE NW 400 WASHINGTON DC 200042654 JENNIFER BREAREY CFO AND COO 2027838700 2023-11-07 1 JENNIFER BREAREY 999009999 0 ROBERT WILLIAMS P01345960 5712279500 2023-11-07 3 AAL1 IAL1 2022 2023-04-26 12:10:37Z ADVAMED SCOTT WHITAKER 1301 PENNSYLVANIA AVE NW 400 WASHINGTON DC 200042654 47870561 0 X WWW.ADVAMED.ORG X 1974 DE REPRESENT MEDICAL DIAGNOSTICS & DEVICE MANUFACTURERS ON REGULATORY & LEGISLATIVE ISSUES. 54 54 100 64 5216 1016 724148 740242 40953240 46843417 67944 157720 106504 129182 41851836 47870561 178000 338500 0 0 22693377 24319592 0 0 0 15589012 19985238 38460389 44643330 3391447 3227231 28228671 41806177 14857438 25198645 13371233 16607532 ADVAMED ADVOCATES ON A GLOBAL BASIS FOR THE HIGHEST ETHICAL STANDARDS, TIMELY PATIENT ACCESS TO SAFE AND EFFECTIVE MEDICAL TECHNOLOGIES, AND ECONOMIC POLICIES THAT REWARD VALUE CREATION. 0 0 ADVAMED'S GOVERNMENT AFFAIRS FUNCTION REPRESENTS THE INDUSTRY BEFORE STATE AND FEDERAL POLICYMAKERS, IN GOVERNOR'S OFFICES, STATE LEGISLATURES, THE UNITED STATES CONGRESS, AND RELEVANT FEDERAL AGENCIES. ADVAMED'S ADVOCACY STAFF AND OUTSIDE CONSULTANTS PROVIDE INFORMATION ON POLITICAL AND POLICY DEVELOPMENTS, AND PURSUE THE INDUSTRY'S AGENDA FOR A LEGAL, REGULATORY AND ECONOMIC ENVIRONMENT THAT ADVANCES HEALTH CARE BY ASSURING PATIENT ACCESS TO THE BENEFITS OF MEDICAL TECHNOLOGY. TAKING MEMBER COMPANY FEEDBACK FROM WORKING GROUPS AND COMMITTEES, ADVAMED STAFF PROVIDE CRITICAL INPUT TO REGULATORY AGENCIES LIKE FDA AND CMS ON REGULATIONS AND RULES THAT IMPACT THE ABILITY FOR PATIENTS TO RECEIVE TIMELY ACCESS TO LIFE CHANGING DEVICES PRODUCED BY ADVAMED MEMBERS. OUR CONSULTANTS IN JAPAN, CHINA, AND OTHER OVERSEAS MARKETS REPRESENT ADVAMED IN RAPIDLY EXPANDING OVERSEAS MARKETS AND ATTEND MEETINGS WITH GOVERNMENT OFFICIALS AND INDUSTRY COMMITTEE MEETINGS. THESE CONSULTANTS PROVIDE REAL-TIME INFORMATION AND AN INDUSTRY VOICE IN OVERSEAS MARKETS. 0 1 0 1 0 0 0 0 0 1 0 0 1 1 1 0 1 0 1 1 0 0 0 0 0 0 1 0 1 0 0 0 0 0 0 0 0 0 0 1 1 1 0 0 1 86 0 100 1 1 1 1 JA CH 0 0 0 0 1 0 X 54 54 0 0 0 0 1 1 1 1 1 0 1 1 1 1 1 1 1 1 1 1 0 X JENNIFER BREAREY 2027838700 1301 PENNSYLVANIA AVE NW SUITE 400 WASHINGTON DC 20004 SCOTT WHITAKER CHIEF EXECUTIVE OFFICER 40.00 X 2203381 0 71983 CHRISTOPHER L WHITE GENERAL COUNSEL & CHIEF POLICY OFFICER 40.00 X 915174 0 68426 JANET TRUNZO EVP, TECH AND REGULATORY AFFAIRS 40.00 X 667536 0 46657 GREG CRIST CHIEF ADVOCACY OFFICER 40.00 X 635483 0 68377 JENNIFER BREAREY CHIEF FINANCIAL & OPERATING OFFICER 40.00 X 567670 0 68426 RAY BRISCUSO EVP, CONFERENCES & EVENTS 40.00 X 496769 0 59375 ANDREW FISH ED, CENTER FOR DIGITAL HEALTH 40.00 X 497296 0 51755 KIMBERLY ZIMMERMAN SVP, HEAD OF FEDERAL GOVERNMENT 40.00 X 476208 0 60186 RICHARD PRICE SVP, PAYMENT & HEALTH CARE DELIVERY POLICY, HEAD O 40.00 X 419232 0 46656 DECHANE DORSEY EVP, PMT & HEALTH CARE DELIVERY POLICY 40.00 X 410270 0 46972 ASHLEY MILLER EVP, GLOBAL STRATEGY & ANALYS 40.00 X 286036 0 5204 MICHAEL MINOGUE CHAIRPERSON 1.00 X X 0 0 0 PETER ARDUINI TREASURER (AS OF 6/2022) 1.00 X X 0 0 0 WALTER ROSEBROUGH TREASURER (UNTIL 6/2022) 1.00 X X 0 0 0 MICHAEL MUSSALLEM SECRETARY 1.00 X X 0 0 0 NACHO ABIA DIRECTOR 1.00 X 0 0 0 ANTOINETTE GAWIN DIRECTOR 1.00 X 0 0 0 ASHLEY MCEVOY DIRECTOR 1.00 X 0 0 0 BRADY SHIRLEY DIRECTOR 1.00 X 0 0 0 BRIAN MILLER DIRECTOR 1.00 X 0 0 0 BRYAN HANSON DIRECTOR 1.00 X 0 0 0 CARLTON ST BERNARD DIRECTOR 1.00 X 0 0 0 CHRISTOPHER SIMON DIRECTOR 1.00 X 0 0 0 DAMIEN MCDONALD DIRECTOR 1.00 X 0 0 0 DAN CARESTIO DIRECTOR 1.00 X 0 0 0 DAVID ENDICOTT DIRECTOR 1.00 X 0 0 0 DAVID PACITTI DIRECTOR 1.00 X 0 0 0 DEEPAK NATH DIRECTOR 1.00 X 0 0 0 ERIC ZACHARIAS DIRECTOR 1.00 X 0 0 0 GEOFF MARTHA DIRECTOR 1.00 X 0 0 0 GEORGE MALIEKEL DIRECTOR 1.00 X 0 0 0 GIUSEPPE ACCOGLI DIRECTOR 1.00 X 0 0 0 JAMES CLEMMER DIRECTOR 1.00 X 0 0 0 JAN DE WITTE DIRECTOR 1.00 X 0 0 0 JAN MAKELA DIRECTOR (UNTIL 3/2022) 1.00 X 0 0 0 JEAN-CLAUDE DUBACHER DIRECTOR 1.00 X 0 0 0 JEFF MIRVISS DIRECTOR 1.00 X 0 0 0 JIM HOLLINGSHEAD DIRECTOR 1.00 X 0 0 0 JOAKIM WEIDEMANIS DIRECTOR 1.00 X 0 0 0 JOHN GROETELAARS DIRECTOR (UNTIL 1/2022) 1.00 X 0 0 0 JOHN LIDDICOAT DIRECTOR (UNTIL 10/2022) 1.00 X 0 0 0 JONATHAN RENNERT DIRECTOR 1.00 X 0 0 0 JOSEPH DEVIVO DIRECTOR (UNTIL 3/2022) 1.00 X 0 0 0 JOSEPH VIRGILIO DIRECTOR 1.00 X 0 0 0 JOSEPH WOODY DIRECTOR 1.00 X 0 0 0 KEN REALI DIRECTOR 1.00 X 0 0 0 KEVIN LOBO DIRECTOR 1.00 X 0 0 0 LIAM KELLY DIRECTOR 1.00 X 0 0 0 LISA EARNHARDT DIRECTOR 1.00 X 0 0 0 LISHAN AKLOG DIRECTOR 1.00 X 0 0 0 MANU VARMA DIRECTOR 1.00 X 0 0 0 MARTHA SHADAN DIRECTOR (UNTIL 10/2022) 1.00 X 0 0 0 MATTHEW SAUSE DIRECTOR 1.00 X 0 0 0 MAUREEN MULVIHILL DIRECTOR 1.00 X 0 0 0 MICHAEL FARRELL DIRECTOR 1.00 X 0 0 0 MICHAEL LYNCH DIRECTOR (UNTIL 2/2022) 1.00 X 0 0 0 NADIM YARED DIRECTOR 1.00 X 0 0 0 NORMAN SCHWARTZ DIRECTOR 1.00 X 0 0 0 RICHARD FABIAN DIRECTOR 1.00 X 0 0 0 ROLAND DIGGELMANN DIRECTOR (UNTIL 3/2022) 1.00 X 0 0 0 SHACEY PETROVIC DIRECTOR (UNTIL 6/2022) 1.00 X 0 0 0 SHARON WOLFINGTON DIRECTOR (UNTIL 10/2022) 1.00 X 0 0 0 STEPHEN MACMILLAN DIRECTOR 1.00 X 0 0 0 STEPHEN MASON DIRECTOR 1.00 X 0 0 0 SVEN SCHMIDT DIRECTOR 1.00 X 0 0 0 THOMAS KAPFER DIRECTOR 1.00 X 0 0 0 THOMAS MCGUINNESS DIRECTOR 1.00 X 0 0 0 THOMAS POLEN DIRECTOR 1.00 X 0 0 0 THOMAS WEST DIRECTOR (UNTIL 5/2022) 1.00 X 0 0 0 TIMOTHY DUGAN DIRECTOR 1.00 X 0 0 0 TODD POPE DIRECTOR 1.00 X 0 0 0 TOM EISIMINGER DIRECTOR 1.00 X 0 0 0 TRACY MACNEAL DIRECTOR 1.00 X 0 0 0 VENK VARADAN DIRECTOR 1.00 X 0 0 0 VITOR ROCHA DIRECTOR 1.00 X 0 0 0 7575055 0 594017 60 0 1 0 HITT CONTRACTING INC 2900 FAIRVIEW PARK DR FALLS CHURCH VA 22042 OFFICE RENOVATION 3634156 HEALTH ADVANCES LLC 275 GROVE STREET SUITE 1-300 NEWTON MA 02466 ADVAMEDDX TESTING SUPPLY REGISTRY 755750 AKIN GUMP STRAUSS HAUER & FELD LLP 2001 K STREET NW WASHINGTON DC 20006 CONGRESSIONAL ADVOCACY & LEGAL 689142 NARRATIVE STRATEGIES LLC 1401 H STREET NW SUITE 750 WASHINGTON DC 20005 GENERAL CONSULTING AND PR SERVICES 595008 CROWELL & MORING LLP 1001 PENNSYLVANIA AVE NW STE 127 WASHINGTON DC 20004 SERVICES RELATED TO MEDICAL DEVICE REGUL 572069 39 740242 740242 MEMBERSHIP DUES 900099 39556990 39556990 MEETINGS & SEMINARS 611430 6255862 6255862 ASSESSMENTS 900099 1030565 1030565 46843417 157720 157720 123966 123966 JOB BOARD REVENUE 900099 5216 5216 5216 47870561 46843417 5216 281686 X 338500 5446304 15373886 1102739 1278567 1118096 824379 69754 2805978 7789304 5109 1109019 137131 1427207 458646 3820429 594935 126411 DUES AND SUBSCRIPTIONS 461743 TRAINING 33408 321785 44643330 498 0 11184723 21353439 2955416 1247782 681539 697636 3301212 886245 1581236 2414967 9085091 1232046 2578205 2515128 161963 12345179 28228671 41806177 8311093 7533539 2770152 1487824 3776193 16177282 14857438 25198645 X 13371233 16607532 13371233 16607532 28228671 41806177 X 3227231 9068 X 0 1 X 1 0 RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 0 0 0 0 0 1 37146987 3177742 -2345958 831784 742940 88844 253359 33297 220062 1330510 273380 1057130 1717343 579568 1137775 2414967 INTERCOMPANY RECEIVABLE 200751 RIGHT OF USE ASSET 12144428 12345179 DEFERRED COMPENSATION 1986749 DEFERRED ASSESSMENTS 1052618 LEASE LIABILITY 13137915 16177282 X PART X, LINE 2: ADVANCED MEDICAL TECHNOLOGY ASSOCIATION (ADVAMED) HAS BEEN RECOGNIZED BY THE INTERNAL REVENUE SERVICE AS EXEMPT FROM U.S. INCOME TAXES UNDER SECTION 501(C)(6) OF THE INTERNAL REVENUE CODE (IRC). THE ASSOCIATION IS NOT EXEMPT FROM U.S. INCOME TAXES ON INCOME FROM ANY UNRELATED BUSINESS ACTIVITIES. ADVAMED COMPLIES WITH THE ACCOUNTING STANDARD ON ACCOUNTING FOR UNCERTAINTY IN INCOME TAXES. MANAGEMENT EVALUATED ADVAMED'S TAX POSITIONS AND CONCLUDED THAT IT HAD TAKEN NO UNCERTAIN TAX POSITIONS THAT REQUIRE ADJUSTMENT TO THE CONSOLIDATED FINANCIAL STATEMENTS TO COMPLY WITH THE PROVISIONS OF THIS GUIDANCE. EAST ASIA AND THE PACIFIC 3 5 PROGRAM SERVICES CONSULTANT IN ASIA MEET WITH GOVERNMENT AND INDUSTRY OFFICIALS 1952609 EAST ASIA AND THE PACIFIC 0 0 PROGRAM SERVICES STAFF TRAVEL TO REGION FOR MEETINGS 31406 EUROPE 0 2 PROGRAM SERVICES CONSULTANT IN EUROPE MEET WITH GOVERNMENT AND INDUSTRY OFFICIALS 173762 EUROPE 0 0 PROGRAM SERVICES STAFF TRAVEL TO REGION FOR MEETINGS 65651 NORTH AMERICA 0 2 PROGRAM SERVICES CONSULTANT IN NORTH AMERICA MEET WITH GOVERNMENT AND INDUSTRY OFFICIALS 456630 NORTH AMERICA 0 0 PROGRAM SERVICES STAFF TRAVEL TO REGION FOR MEETINGS 579 SOUTH AMERICA 0 2 PROGRAM SERVICES ALLIANCE WITH LOCAL ORGANIZATION TO SUPPORT COMMON ISSUES 411830 SOUTH AMERICA 0 0 PROGRAM SERVICES STAFF TRAVEL TO REGION FOR MEETINGS 9586 SOUTH ASIA 0 2 PROGRAM SERVICES CONSULTANTS IN INDIA MEET WITH GOVERNMENT AND INDUSTRY OFFICIALS 266624 SUB-SAHARAN AFRICA 0 0 PROGRAM SERVICES STAFF TRAVEL TO REGION FOR MEETINGS 3206 3 11 0 2 3 13 3102053 269830 3371883 0 0 0 0 0 0 PART III ACCOUNTING METHOD: 1 SANDY HOOK PROMISE FOUNDATION INC PO BOX 3489 NEWTON CT 06470 461657101 501(C)(3) 10000 0 N/A N/A PROGRAM SUPPORT NATIONAL WOMENS HEALTH RESOURCE CENTER INC PO BOX 336 MIDDLETOWN NJ 07748 521624846 501(C)(3) 10000 0 N/A N/A PROGRAM SUPPORT NATIONAL CONFERENCE OF STATE LEGISLATURES (NCSL) 7700 E FIRST PLACE DENVER CO 80230 742232576 501(C)(3) 10000 0 N/A N/A PROGRAM SUPPORT FRIENDS OF CANCER RESEARCH 1800 M ST NW SUITE 1050 SOUTH WASHINGTON DC 20036 521983273 501(C)(3) 10000 0 N/A N/A PROGRAM SUPPORT ENVIRONMENTAL COUNCIL OF THE STATES (ECOS) 1250 H STREET NW SUITE 850 WASHINGTON DC 20005 363962169 501(C)(6) 10000 0 N/A N/A PROGRAM SUPPORT PREVENT CANCER FOUNDATION 1600 DUKE STREET SUITE 500 ALEXANDRIA VA 22314 521429544 501(C)(3) 10000 0 N/A N/A PROGRAM SUPPORT MEDTECH COLOR 4940 PASO ROBLES AVENUE 209 ENCINO CA 91436 830543603 501(C)(3) 10000 0 N/A N/A PROGRAM SUPPORT WASHINGTON LEGAL FOUNDATION 2009 MASSACHUSETTS AVE NW WASHINGTON DC 20036 521071570 501(C)(3) 15000 0 N/A N/A PROGRAM SUPPORT GEORGE MASON UNIVERSITY FOUNDATION INC 4400 UNIVERSITY DRIVE MS 1A3 FAIRFAX VA 22030 541603842 501(C)(3) 15000 0 N/A N/A PROGRAM SUPPORT INTERNATIONAL CENTER FOR PROFESSIONAL DEVELOPMENT 27890 CLINTON KEITH ROAD SUITE D314 MURRIETA CA 92562 274244677 501(C)(3) 20000 0 N/A N/A PROGRAM SUPPORT MEDTECHVETS 10 VILLA ROAD SOUTH HAMILTON MA 01982 465019277 501(C)(3) 25000 0 N/A N/A PROGRAM SUPPORT UNITED SPINAL ASSOCIATION 120-34 QUEENS BLVD STE 320 KEW GARDENS NY 11415 135612621 501(C)(3) 30000 0 N/A N/A PROGRAM SUPPORT AMERICAN CANCER SOCIETY CANCER ACTION NETWORK 655 15TH STREET NW SUITE 503 WASHINGTON DC 20005 522340031 501(C)(4) 35000 0 N/A N/A PROGRAM SUPPORT ALLIANCE FOR AGING RESEARCH 1700 K STREET NW STE 740 WASHINGTON DC 20006 541379174 501(C)(3) 35000 0 N/A N/A PROGRAM SUPPORT RESEARCHAMERICA 241 18TH STREET SOUTH STE 501 ARLINGTON VA 22202 521609875 501(C)(3) 35000 0 N/A N/A PROGRAM SUPPORT JUVENILE DIABETES RESEARCH FOUNDATION (JDRF) 1400 K STREET NW SUITE 725 WASHINGTON DC 20005 510150028 501(C)(3) 50000 0 N/A N/A PROGRAM SUPPORT 14 2 PART I, LINE 2: ADVAMED BUDGETS ANNUALLY FOR CHARITABLE DONATIONS AND OTHER CHARITABLE GIVING THAT IS CLOSELY ALIGNED WITH ITS STRATEGIC PLAN AND MISSION. IN ADDITION, ADVAMED MAY IDENTIFY CAUSES THROUGHOUT THE YEAR THAT MAY REQUIRE REPURPOSING OF FUNDS FROM ANOTHER EXPENSE CATEGORY TO SUPPORT CERTAIN MEDICAL DEVICE ISSUES OR MEMBERSHIP INITIATIVES, ALL SUCH SPENDING IS PROCESSED THROUGH ADVAMED'S PURCHASE ORDER SYSTEM, WHICH REQUIRES SEVERAL LEVELS OF EXECUTIVE APPROVAL BEFORE ANY FUNDING IS MADE. X X 1 1 X X X X X 0 0 0 SCOTT WHITAKER CHIEF EXECUTIVE OFFICER 1319977 0 881082 0 2322 0 35240 0 36743 0 2275364 0 0 0 CHRISTOPHER L WHITE GENERAL COUNSEL & CHIEF POLICY OFFIC 709726 0 203126 0 2322 0 35240 0 33186 0 983600 0 0 0 JANET TRUNZO EVP, TECH AND REGULATORY AFFAIRS 523989 0 138603 0 4944 0 35240 0 11417 0 714193 0 0 0 GREG CRIST CHIEF ADVOCACY OFFICER 536373 0 97868 0 1242 0 35240 0 33137 0 703860 0 0 0 JENNIFER BREAREY CHIEF FINANCIAL & OPERATING OFFICER 431694 0 135166 0 810 0 35240 0 33186 0 636096 0 0 0 RAY BRISCUSO EVP, CONFERENCES & EVENTS 409107 0 84098 0 3564 0 35240 0 24135 0 556144 0 0 0 ANDREW FISH ED, CENTER FOR DIGITAL HEALTH 322477 0 173658 0 1161 0 35240 0 16515 0 549051 0 0 0 KIMBERLY ZIMMERMAN SVP, HEAD OF FEDERAL GOVERNMENT 381098 0 95110 0 0 0 27049 0 33137 0 536394 0 0 0 RICHARD PRICE SVP, PAYMENT & HEALTH CARE DELIVERY 351558 0 62730 0 4944 0 35240 0 11416 0 465888 0 0 0 DECHANE DORSEY EVP, PMT & HEALTH CARE DELIVERY POLI 339988 0 69040 0 1242 0 35240 0 11732 0 457242 0 0 0 ASHLEY MILLER EVP, GLOBAL STRATEGY & ANALYS 284949 0 0 0 1087 0 4129 0 1075 0 291240 0 0 0 PART I, LINE 1A FIRST CLASS TRAVEL IS AUTHORIZED ONLY IN EXCEPTIONAL CIRCUMSTANCES, SUCH AS WHEN IT IS NECESSARY TO TAKE A SPECIFIC FLIGHT WHERE BUSINESS OR COACH CLASS IS NOT AVAILABLE, AND MUST FIRST HAVE PRIOR WRITTEN APPROVAL BY DEPARTMENT HEADS AND ADVAMED'S PRESIDENT. OTHER EXPENSES INCURRED BY THE TRAVELER FOR TRAVEL OUTSIDE THE DEFINITION OF A BUSINESS TRIP, INCLUDING EXPENSES FOR FAMILY MEMBERS TRAVELING WITH THE EMPLOYEE, ARE ALSO THE RESPONSIBILITY OF THE TRAVELER AND NOT ADVAMED. SUCH EXPENSES ARE KEPT SEPARATE FROM REIMBURSABLE BUSINESS EXPENDITURES. PERSONAL TRAVEL FOR FAMILY MEMBERS/FRIENDS MAY BE BOOKED THROUGH ADVAMED'S TRAVEL AGENCY BUT ARE IDENTIFIED SEPARATELY AND BILLED DIRECTLY TO THE EMPLOYEE. THE CEO OF ADVAMED MAY TRAVEL BUSINESS CLASS ON ALL INTERNATIONAL FLIGHTS AND FOR TRAVEL OVER THREE HOURS IN DURATION WHERE SUCH SEATING IS AVAILABLE. FIRST CLASS SEATING WILL BE REIMBURSED ON DOMESTIC FLIGHTS OVER THREE (3) HOURS IN DURATION IF BUSINESS CLASS SEATING IS NOT OFFERED ON THE FLIGHT. THE ASSOCIATION SHALL REIMBURSE TRAVEL EXPENSES FOR EXECUTIVE'S SPOUSE TO ASSOCIATION EVENTS WHEN ATTENDANCE IS REQUIRED FOR BUSINESS PURPOSES. TRAVEL IS NOT INCLUDED IN TAXABLE INCOME. FORM 990, PART VI, SECTION A, LINE 1A THERE SHALL BE AN EXECUTIVE COMMITTEE, WHICH SHALL CONSIST OF THE PRESIDENT, ELECTED OFFICERS OF THE ASSOCIATION, THE IMMEDIATE PAST CHAIR, THE ADVAMED-DX CHAIR, THE ADVAMED ACCEL CHAIR, THE BOARD TECHNOLOGY AND REGULATION COMMITTEE CHAIR, THE BOARD PAYMENT AND HEALTH CARE DELIVERY POLICY COMMITTEE CHAIR, THE INTERNATIONAL BOARD COMMITTEE CHAIR AND NOT FEWER THAN THREE NOR MORE THAN EIGHT MEMBERS OF THE BOARD OF DIRECTORS AT LARGE, WHO SHALL BE ELECTED TO THAT POSITION, FOR A PERIOD OF ONE YEAR AND THEREAFTER UNTIL A SUCCESSOR SHALL HAVE BEEN DULY ELECTED AND QUALIFIED, BY A MAJORITY OF THE ENTIRE BOARD OF DIRECTORS ANNUALLY. THE CHAIR SHALL ACT AS CHAIR OF THE EXECUTIVE COMMITTEE. THE EXECUTIVE COMMITTEE SHALL PERFORM SUCH DUTIES AS MAY BE DELEGATED TO IT BY THE BOARD OF DIRECTORS, AND MAY FURTHER ACT FOR AND ON BEHALF OF THE BOARD OF DIRECTORS BETWEEN MEETINGS OF THE BOARD OF DIRECTORS, PROVIDED THAT ALL SUCH ACTS SHALL BE FULLY REPORTED TO THE BOARD OF DIRECTORS AT OR BEFORE ITS NEXT MEETING FOR ITS REVIEW AND APPROPRIATE ACTION, IF REQUIRED OR DEEMED NECESSARY. FORM 990, PART VI, SECTION A, LINE 6 ANY FIRM OR CORPORATION WHICH, THROUGH ITSELF OR THROUGH ANY OF ITS SUBSIDIARIES OR DIVISIONS, IS SIGNIFICANTLY ENGAGED IN THE MANUFACTURE OF AND/OR THE RESEARCH WITH THE INTENT TO MANUFACTURE MEDICAL DEVICES, DIAGNOSTIC PRODUCTS AND/OR HEALTH CARE INFORMATION SYSTEMS WITHIN THE UNITED STATES, ITS TERRITORIES AND POSSESSIONS, SHALL BE ELIGIBLE FOR ACTIVE MEMBERSHIP. FORM 990, PART VI, SECTION A, LINE 7A EACH ACTIVE MEMBER IN GOOD STANDING SHALL BE ENTITLED TO ONE VOTE ON ANY QUESTION COMING BEFORE THE GENERAL MEMBERSHIP, INCLUDING THE ELECTION OF ONE THIRD OF THE BOARD OF DIRECTORS ANNUALLY. THE BOARD NOMINATING AND GOVERNANCE COMMITTEE PRESENTS A PROPOSED SLATE OF DIRECTORS ANNUALLY TO THE MEMBERSHIP FOR VOTE. EACH ACTIVE MEMBER SHALL, IN WRITING, DESIGNATE ITS OFFICIAL REPRESENTATIVE TO VOTE AND REPRESENT THAT MEMBER IN ALL OF THE AFFAIRS OF THE ASSOCIATION, INCLUDING THE HOLDING OF OFFICE. FORM 990, PART VI, SECTION A, LINE 7B EACH ACTIVE MEMBER IN GOOD STANDING SHALL BE ENTITLED TO ONE VOTE ON ANY QUESTION COMING BEFORE THE GENERAL MEMBERSHIP. EACH ACTIVE MEMBER SHALL, IN WRITING, DESIGNATE ITS OFFICIAL REPRESENTATIVE TO VOTE AND REPRESENT THAT MEMBER IN ALL OF THE AFFAIRS OF THE ASSOCIATION, INCLUDING THE HOLDING OF OFFICE. SUCH OFFICIAL REPRESENTATIVE SHALL BE THE CHIEF EXECUTIVE OFFICER OR CHIEF OPERATING OFFICER OF THE MEMBER OR SUCH OTHER SENIOR OPERATING OFFICER AS THE CHIEF EXECUTIVE OFFICER MAY DESIGNATE. FORM 990, PART VI, SECTION B, LINE 11B ADVAMED'S CHIEF FINANCIAL & OPERATING OFFICER AND VP FINANCE/CONTROLLER PERFORM AN INDEPTH REVIEW OF THE DRAFT 990. THE GENERAL COUNSEL REVIEWS THE FINAL DRAFT PRIOR TO SUBMITTING TO THE FINANCE, AUDIT AND COMPENSATION COMMITTEE (FAC). UPON THE FAC'S REVIEW THE 990 IS SUBMITTED TO THE FULL BOARD FOR THEIR REVIEW. PROVIDED NO CONCERNS ARE RAISED PRIOR TO THE END OF ADVANCED MEDICAL TECHNOLOGY ASSOCIATION 52-1006053 THE REVIEW PERIOD, THE 990 IS THEN FINALIZED AND SUBMITTED TO THE IRS. FORM 990, PART VI, SECTION B, LINE 12C ADVAMED HAS IN PLACE A CONFLICT OF INTEREST POLICY THAT IS MONITORED REGULARLY. EXCERPTS FROM THE POLICY RELATED TO THIS QUESTION ARE SHOWN BELOW: THE CONFLICT OF INTEREST POLICY OF ADVAMED: (1) DEFINES CONFLICTS OF INTEREST; (2) IDENTIFIES CLASSES OF INDIVIDUALS WITHIN THE ASSOCIATION COVERED BY THIS POLICY; (3) FACILITATES DISCLOSURE OF INFORMATION THAT MAY HELP IDENTIFY CONFLICTS OF INTEREST; AND (4) SPECIFIES PROCEDURES TO BE FOLLOWED IN MANAGING CONFLICTS OF INTEREST. 1. A CONFLICT OF INTEREST ARISES WHEN A PERSON IN A POSITION OF AUTHORITY OVER THE ASSOCIATION MAY BENEFIT FINANCIALLY FROM A DECISION HE OR SHE COULD MAKE IN THAT CAPACITY, INCLUDING INDIRECT BENEFITS SUCH AS TO FAMILY MEMBERS OR BUSINESSES WITH WHICH THE PERSON IS CLOSELY ASSOCIATED. ADVAMED'S POLICY IS FOCUSED UPON MATERIAL FINANCIAL INTEREST OF, OR BENEFIT TO, SUCH PERSONS. 2. PERSONS COVERED BY THIS POLICY ARE THE ASSOCIATION'S STAFF, OFFICERS, DIRECTORS, AND CHIEF EXECUTIVE OFFICER. 3. PERSONS COVERED BY THIS POLICY ANNUALLY DISCLOSE TO THE GENERAL COUNSEL ON A FORM PROVIDED BY THE ASSOCIATION THEIR INTERESTS THAT COULD GIVE RISE TO CONFLICTS OF INTEREST, SUBSTANTIAL BUSINESS OR INVESTMENT HOLDINGS, AND OTHER TRANSACTIONS OR AFFILIATIONS WITH BUSINESSES AND OTHER ORGANIZATIONS OR THOSE OF FAMILY MEMBERS. 4. FOR EACH INTEREST DISCLOSED TO THE GENERAL COUNSEL, THE GENERAL COUNSEL WILL DETERMINE WHETHER TO: (A) TAKE NO ACTION; (B) ASSURE FULL DISCLOSURE TO THE BOARD OF DIRECTORS AND OTHER INDIVIDUALS COVERED BY THIS POLICY; (C) ASK THE PERSON TO RECUSE FROM PARTICIPATION IN RELATED DISCUSSIONS OR DECISIONS WITHIN THE ASSOCIATION; OR (D) ASK THE PERSON TO RESIGN FROM HIS OR HER POSITION IN THE ASSOCIATION OR, IF THE PERSON REFUSES TO RESIGN, BECOME SUBJECT TO POSSIBLE REMOVAL IN ACCORDANCE WITH THE ASSOCIATION'S REMOVAL PROCEDURES. THE ASSOCIATION'S OFFICERS WILL MONITOR PROPOSED OR ONGOING TRANSACTIONS FOR CONFLICTS OF INTEREST AND DISCLOSE THEM TO THE CHAIRMAN OF THE BOARD OF DIRECTORS IN ORDER TO DEAL WITH POTENTIAL OR ACTUAL CONFLICTS, WHETHER DISCOVERED BEFORE OR AFTER THE TRANSACTION HAS OCCURRED. INTERESTS IN MEMBER COMPANIES: AT TIMES, ADVAMED STAFF AND/OR DIRECTORS MAY BE AWARE OF THE SIGNIFICANT AMOUNT OF INTEREST GENERATED IN CONNECTION WITH NEW PRODUCT DEVELOPMENT, SALES AND PROFITS, PRODUCT REGULATORY STATUS, AND ACQUISITIONS IN THE HEALTH CARE TECHNOLOGY INDUSTRY, THUS, ANYONE IN POSSESSION OF MATERIAL INFORMATION NOT GENERALLY AVAILABLE TO THE INVESTING PUBLIC MUST, IN ORDER TO COMPLY WITH THIS POLICY, EITHER DISCLOSE THAT KNOWLEDGE OR REFRAIN FROM TRADING IN THE STOCK. IN ADDITION, THE PURCHASE OF STOCK IN MEMBER COMPANIES CAN LEAD TO THE APPEARANCE THAT A MEMBER OF THE STAFF AND/OR BOARD OF DIRECTORS IS FAVORING THE INTERESTS OF THAT COMPANY BECAUSE OF SUCH FINANCIAL INTEREST. EVEN IF THERE IS NO ACTUAL CONFLICT OF INTEREST, THE APPEARANCE OF IMPROPRIETY MUST BE AVOIDED. NO EMPLOYEE OF THE ASSOCIATION OR MEMBER OF ITS BOARD OF DIRECTORS, EITHER IN HIS OR HER OWN NAME, OR IN THE NAME OF HIS OR HER SPOUSE OR CHILDREN, MAY PURCHASE STOCK IN ANY MEMBER COMPANY WITHOUT ADVISING THE ASSOCIATION PRESIDENT OF SUCH OWNERSHIP OR CONTEMPLATED OWNERSHIP. IN 2010, ADVAMED REQUIRED EMPLOYEES AND DIRECTORS TO SUBMIT AN ANNUAL FINANCIAL DISCLOSURE STATEMENT TO THE GENERAL COUNSEL REGARDING HOLDINGS IN MEMBER COMPANIES. AFTER REVIEW OF THE COMPLETED FORMS BY THE GENERAL COUNSEL, POTENTIAL CONFLICTS ARE REPORTED TO THE PRESIDENT, WHO REPORTS ANY SUCH DISCLOSURES TO THE CHAIRMAN OF THE BOARD OF DIRECTORS. INTEREST IN ENTITIES DOING BUSINESS WITH ADVAMED: IN THE COURSE OF ITS DAY-TO-DAY OPERATIONS, ADVAMED CONTRACTS WITH NUMEROUS FIRMS THAT PROVIDE GOODS AND SERVICES. IT IS IMPORTANT THAT THESE FIRMS ARE CHOSEN FOR BUSINESS PURPOSES AND NOT BECAUSE THEY ARE INAPPROPRIATELY FAVORED BY ADVAMED EMPLOYEES OR DIRECTORS WHO MAY HAVE A FINANCIAL INTEREST IN PARTICULAR TRANSACTIONS. ACCORDINGLY, ADVAMED EMPLOYEES AND DIRECTORS MUST DISCLOSE, ON AN ONGOING BASIS, ANY FINANCIAL INTEREST IN A COMPANY WITH WHICH ADVAMED CONTRACTS, OR IS CONSIDERING. FORM 990, PART VI, SECTION B, LINE 15 THE PROCESS INCLUDES ALL OF THESE ELEMENTS: (1) REVIEW AND APPROVAL BY THE COMPENSATION SUBCOMMITTEE OF THE FINANCE, AUDIT AND COMPENSATION COMMITTEE OF THE ASSOCIATION; (2) USE OF DATA AS TO COMPARABLE COMPENSATION; AND (3) CONTEMPORANEOUS DOCUMENTATION AND RECORDKEEPING. 1. REVIEW AND APPROVAL: THE COMPENSATION OF THE PERSON IS REVIEWED AND APPROVED BY THE BOARD COMMITTEE ON FINANCE, AUDIT AND COMPENSATION OF THE ASSOCIATION, PROVIDED THAT PERSONS WITH CONFLICTS OF INTEREST WITH RESPECT TO THE COMPENSATION ARRANGEMENT AT ISSUE ARE NOT INVOLVED IN THIS REVIEW AND APPROVAL. 2. USE OF DATA AS TO COMPARABLE COMPENSATION: THE COMPENSATION OF THE PERSON IS REVIEWED AND APPROVED USING DATA AS TO COMPARABLE COMPENSATION FOR SIMILARLY QUALIFIED PERSONS IN FUNCTIONALLY COMPARABLE POSITIONS AT SIMILARLY SITUATED ORGANIZATIONS. 3. CONTEMPORANEOUS DOCUMENTATION AND RECORDKEEPING: THERE IS CONTEMPORANEOUS DOCUMENTATION AND RECORDKEEPING WITH RESPECT TO THE DELIBERATIONS AND DECISIONS REGARDING THE COMPENSATION ARRANGEMENT. THE PROCESS RECENTLY TOOK PLACE IN 2022. FORM 990, PART VI, SECTION C, LINE 19 THE ORGANIZATION'S FINANCIAL STATEMENTS, CONFLICT OF INTEREST POLICY AND GOVERNING DOCUMENTS ARE AVAILABLE UPON REQUEST FOR THE SAME PERIOD OF DISCLOSURE AS SET FORTH IN SECTION 6104(D). FORM 990, PART IX, LINE 11G OTHER CONSULTING EXPENSE 7,726,138. PAYROLL PROCESSING FEE 63,166. FORM 990, PART XI, LINE 9: CHANGE IN EQUITY IN ADVAMED PURCHASING GROUP 9,068. MEDTECH CONFERENCE PARTNERS LLC 1301 PENNSYLVANIA AVE SUITE 400 WASHINGTON DC 20004 364725626 TRADE SHOW DC 0 0 ADVANCED MEDICAL TECHNOLOGY ASSOCIATION ADVANCED MEDICAL TECHNOLOGY ASSOCIATION PAC 1301 PENNSYLVANIA AVE STE 400 WASHINGTON DC 20004 522134566 POLITICAL ACTION COMMITTEE DC 527 ADVANCED MEDICAL TECHNOLOGY ASSOCIATION 1 ADVANCED MEDICAL TECHNOLOGY ASSOCIATION CA PAC 1301 PENNSYLVANIA AVE STE 400 WASHINGTON DC 20004 455309081 POLITICAL ACTION COMMITTEE DC 527 ADVANCED MEDICAL TECHNOLOGY ASSOCIATION 1 ADVAMED PURCHASING GROUP INC 1301 PENNSYLVANIA AVE SUITE 400 WASHINGTON DC 20004 812764022 GROUP PURCHASING PROGRAM DC ADVANCED MEDICAL TECHNOLOGY ASSOCIATION C 38824 200751 1.00000 1 0 0 0 0 0 0 0 0 0 0 0 0 0 1 1 0 1 0 1